vs
Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.0B, roughly 1.5× Everus Construction Group, Inc.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs -13.6%, a 19.1% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
ECG vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.5B |
| Net Profit | $55.3M | $-205.0M |
| Gross Margin | 11.6% | 49.2% |
| Operating Margin | 6.8% | -9.8% |
| Net Margin | 5.5% | -13.6% |
| Revenue YoY | 33.2% | -5.3% |
| Net Profit YoY | 60.4% | -288.1% |
| EPS (diluted) | $1.09 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $986.8M | $1.6B | ||
| Q2 25 | $921.5M | $1.6B | ||
| Q1 25 | $826.6M | $1.5B | ||
| Q4 24 | $759.6M | $1.6B | ||
| Q3 24 | $761.0M | $1.6B | ||
| Q2 24 | $703.4M | $1.6B | ||
| Q1 24 | $625.7M | $1.6B |
| Q4 25 | $55.3M | $-205.0M | ||
| Q3 25 | $57.0M | $160.0M | ||
| Q2 25 | $52.8M | $145.0M | ||
| Q1 25 | $36.7M | $87.0M | ||
| Q4 24 | $34.5M | $109.0M | ||
| Q3 24 | $41.8M | $359.0M | ||
| Q2 24 | $39.0M | $195.0M | ||
| Q1 24 | $28.2M | $201.0M |
| Q4 25 | 11.6% | 49.2% | ||
| Q3 25 | 12.6% | 53.5% | ||
| Q2 25 | 13.0% | 54.8% | ||
| Q1 25 | 11.2% | 55.6% | ||
| Q4 24 | 11.4% | 56.3% | ||
| Q3 24 | 11.8% | 58.3% | ||
| Q2 24 | 12.6% | 58.4% | ||
| Q1 24 | 11.9% | 59.0% |
| Q4 25 | 6.8% | -9.8% | ||
| Q3 25 | 7.3% | 15.2% | ||
| Q2 25 | 7.9% | 14.4% | ||
| Q1 25 | 6.2% | 6.7% | ||
| Q4 24 | 6.1% | 8.1% | ||
| Q3 24 | 7.1% | 13.1% | ||
| Q2 24 | 7.3% | 14.6% | ||
| Q1 24 | 6.2% | 14.5% |
| Q4 25 | 5.5% | -13.6% | ||
| Q3 25 | 5.8% | 10.0% | ||
| Q2 25 | 5.7% | 9.1% | ||
| Q1 25 | 4.4% | 5.8% | ||
| Q4 24 | 4.5% | 6.8% | ||
| Q3 24 | 5.5% | 22.7% | ||
| Q2 24 | 5.5% | 12.1% | ||
| Q1 24 | 4.5% | 12.4% |
| Q4 25 | $1.09 | $-0.78 | ||
| Q3 25 | $1.11 | $0.61 | ||
| Q2 25 | $1.03 | $0.56 | ||
| Q1 25 | $0.72 | $0.33 | ||
| Q4 24 | $0.68 | $0.42 | ||
| Q3 24 | $0.82 | $1.38 | ||
| Q2 24 | $0.76 | $0.75 | ||
| Q1 24 | $0.55 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $574.0M |
| Total DebtLower is stronger | $281.5M | $8.6B |
| Stockholders' EquityBook value | $629.8M | $752.0M |
| Total Assets | $1.7B | $12.9B |
| Debt / EquityLower = less leverage | 0.45× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $574.0M | ||
| Q3 25 | — | $672.0M | ||
| Q2 25 | — | $599.0M | ||
| Q1 25 | — | $547.0M | ||
| Q4 24 | — | $675.0M | ||
| Q3 24 | $553.0K | $763.0M | ||
| Q2 24 | — | $704.0M | ||
| Q1 24 | — | $575.0M |
| Q4 25 | $281.5M | $8.6B | ||
| Q3 25 | $285.1M | $8.8B | ||
| Q2 25 | $288.6M | $8.9B | ||
| Q1 25 | $292.1M | $9.0B | ||
| Q4 24 | $295.6M | $8.9B | ||
| Q3 24 | — | $8.7B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.7B |
| Q4 25 | $629.8M | $752.0M | ||
| Q3 25 | $573.0M | $906.0M | ||
| Q2 25 | $514.4M | $733.0M | ||
| Q1 25 | $460.2M | $542.0M | ||
| Q4 24 | $422.6M | $472.0M | ||
| Q3 24 | $453.3M | $493.0M | ||
| Q2 24 | $490.0M | $144.0M | ||
| Q1 24 | $464.3M | $48.0M |
| Q4 25 | $1.7B | $12.9B | ||
| Q3 25 | $1.6B | $13.6B | ||
| Q2 25 | $1.5B | $13.5B | ||
| Q1 25 | $1.4B | $13.2B | ||
| Q4 24 | $1.3B | $13.1B | ||
| Q3 24 | $1.3B | $12.8B | ||
| Q2 24 | — | $12.2B | ||
| Q1 24 | — | $11.9B |
| Q4 25 | 0.45× | 11.49× | ||
| Q3 25 | 0.50× | 9.74× | ||
| Q2 25 | 0.56× | 12.14× | ||
| Q1 25 | 0.63× | 16.52× | ||
| Q4 24 | 0.70× | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $48.2M | $141.0M |
| Free Cash FlowOCF − Capex | $23.5M | $96.0M |
| FCF MarginFCF / Revenue | 2.3% | 6.4% |
| Capex IntensityCapex / Revenue | 2.4% | 3.0% |
| Cash ConversionOCF / Net Profit | 0.87× | — |
| TTM Free Cash FlowTrailing 4 quarters | $90.0M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $48.2M | $141.0M | ||
| Q3 25 | $76.2M | $264.0M | ||
| Q2 25 | $25.3M | $220.0M | ||
| Q1 25 | $7.1M | $75.0M | ||
| Q4 24 | — | $390.0M | ||
| Q3 24 | $78.9M | $141.0M | ||
| Q2 24 | — | $332.0M | ||
| Q1 24 | $21.9M | $76.0M |
| Q4 25 | $23.5M | $96.0M | ||
| Q3 25 | $65.7M | $218.0M | ||
| Q2 25 | $12.3M | $181.0M | ||
| Q1 25 | $-11.4M | $43.0M | ||
| Q4 24 | — | $335.0M | ||
| Q3 24 | $60.9M | $99.0M | ||
| Q2 24 | — | $300.0M | ||
| Q1 24 | $12.6M | $30.0M |
| Q4 25 | 2.3% | 6.4% | ||
| Q3 25 | 6.7% | 13.6% | ||
| Q2 25 | 1.3% | 11.4% | ||
| Q1 25 | -1.4% | 2.8% | ||
| Q4 24 | — | 21.0% | ||
| Q3 24 | 8.0% | 6.3% | ||
| Q2 24 | — | 18.7% | ||
| Q1 24 | 2.0% | 1.8% |
| Q4 25 | 2.4% | 3.0% | ||
| Q3 25 | 1.1% | 2.9% | ||
| Q2 25 | 1.4% | 2.4% | ||
| Q1 25 | 2.2% | 2.1% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | 2.4% | 2.7% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | 1.5% | 2.8% |
| Q4 25 | 0.87× | — | ||
| Q3 25 | 1.34× | 1.65× | ||
| Q2 25 | 0.48× | 1.52× | ||
| Q1 25 | 0.19× | 0.86× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | 1.89× | 0.39× | ||
| Q2 24 | — | 1.70× | ||
| Q1 24 | 0.77× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ECG
| Commercial | $594.5M | 59% |
| Utility | $203.5M | 20% |
| Industrial | $82.8M | 8% |
| Institutional | $66.1M | 7% |
| Service And Other | $28.4M | 3% |
| Transportation | $24.2M | 2% |
| Renewables | $19.8M | 2% |
OGN
Segment breakdown not available.
